DNO ASA A NK -,25/ NO0003921009 /
30.05.2024 08:24:06 | Diff. 0.000 | Volumen | Geld08:30:58 | Brief08:30:58 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
0.975EUR | 0.00% | 0 Umsatz: 0.000 |
0.974Geld Vol: 3'500 | 1.013Brief Vol: 3'500 | 0.975 | 0.975 |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite